Medizinische Universität Innsbruck

Jul 11, 2024 | gut.bmj.com | Alessandro Mantovani |Herbert Tilg |Giovanni Targher |Medizinische Universität Innsbruck

FGF-21 analogues for treatment of non-alcoholic steatohepatitis and fibrosis: a meta-analysis with fragility index of phase 2 randomised placebo-controlled trials Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Jun 24, 2024 | hvg.hu | Medizinische Universität Innsbruck

Osztrák kutatók szerint jobb lehet azoknak a betegeknek az életminősége, akiknek a szívét a koszorúér-műtét után hanghullámokkal is kezelik. Az Egészségügyi Világszervezet adatai szerint világszerte évente mintegy 18 millió ember hal meg szívbetegségben vagy egyéb szív- és érrendszeri szövődményekben. A kockázati tényezők közé tartozik a magas vérnyomás és az egészségtelen táplálkozás, valamint a dohányzás és az alkoholfogyasztás is.

Jun 6, 2024 | gut.bmj.com | Timon E. Adolph |Medizinische Universität Innsbruck

Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Apr 25, 2024 | academic.oup.com | HIV unit |Tropical Diseases |Medizinische Universität Innsbruck

Mortality among people with HIV declined with the introduction of combination antiretroviral therapy. We investigated trends over time in all-cause and cause-specific mortality in people with HIV from 1999—2020. Data were collected from the D:A:D cohort from 1999 through January 2015 and RESPOND from October 2017 through 2020. Age-standardized all-cause and cause-specific mortality rates, classified using Coding Causes of Death in HIV (CoDe), were calculated.

Mar 7, 2024 | gut.bmj.com | Christopher Byrne |Giovanni Targher |Herbert Tilg |Medizinische Universität Innsbruck

CVD risk assessment in MASLDThe first consideration is how CVD risk should be assessed in patients with MASLD? Most patients with MASLD are likely to be middle-aged, and although there are exceptions, women with MASLD are most likely to be perimenopausal or postmenopausal. Because of the age demographic of patients with MASLD, this patient group should be considered for a CVD health check as most patients will be >40 years old.